Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells
dc.contributor.author | Lanza, | en_US |
dc.contributor.author | Castoldi, | en_US |
dc.contributor.author | Castagnar, | en_US |
dc.contributor.author | Todd, | en_US |
dc.contributor.author | Moretti, | en_US |
dc.contributor.author | Spisani, | en_US |
dc.contributor.author | Latorraca, | en_US |
dc.contributor.author | Focarile, | en_US |
dc.contributor.author | Roberti, | en_US |
dc.contributor.author | Traniello, | en_US |
dc.date.accessioned | 2010-06-01T21:40:01Z | |
dc.date.available | 2010-06-01T21:40:01Z | |
dc.date.issued | 1998-10 | en_US |
dc.identifier.citation | Lanza, ; Castoldi, ; Castagnar, ; Todd, ; Moretti, ; Spisani, ; Latorraca, ; Focarile, ; Roberti, ; Traniello, (1998). "Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells." British Journal of Haematology 103(1): 110-123. <http://hdl.handle.net/2027.42/74714> | en_US |
dc.identifier.issn | 0007-1048 | en_US |
dc.identifier.issn | 1365-2141 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74714 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9792297&dopt=citation | en_US |
dc.format.extent | 1297134 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | 1998 Blackwell Science Ltd | en_US |
dc.subject.other | UPA-R | en_US |
dc.subject.other | Acute Myeloid Leukaemia | en_US |
dc.subject.other | AML M5 Morphology | en_US |
dc.subject.other | Tissue Infiltration | en_US |
dc.subject.other | Chromosome Abnormalities | en_US |
dc.title | Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationother | Department of Biochemistry and Molecular Biology, University of Ferrara, Italy | en_US |
dc.identifier.pmid | 9792297 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74714/1/j.1365-2141.1998.00932.x.pdf | |
dc.identifier.doi | 10.1046/j.1365-2141.1998.00932.x | en_US |
dc.identifier.source | British Journal of Haematology | en_US |
dc.identifier.citedreference | BenÈ, M., Castoldi, G.L., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A., van't Veer, M.B., on behalf of the European Group for the Immunological Characterization of Leukemias, EGIL ( 1995 ) Proposals for the immunological classification of acute leukemias. Leukemia, 9, 1783 1786. | en_US |
dc.identifier.citedreference | Bennett, B., Croll, A.M., Robbie, L.A., Herriot, R. ( 1997 ) Tumour cell u-PA as a cause of fibrinolytic bleeding in metastatic disease. British Journal of Haematology, 99, 570 574. | en_US |
dc.identifier.citedreference | Borregaard, N. & Cowland, J. ( 1997 ) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503 3521. | en_US |
dc.identifier.citedreference | Bu, G., Warshawsky, I., Schwartz, A.L. ( 1994 ) Cellular receptors for the plasminogen activators. Blood, 83, 3427 3436. | en_US |
dc.identifier.citedreference | Cao, D., Mizukani, I.F., Garni-Wagner, B.A., Kindzelsky, A.L., Todd, R.F. ( 1995 ) Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type 3 and calcium. Journal of Immunology, 154, 1817 1829. | en_US |
dc.identifier.citedreference | Castoldi, G.L. & Cuneo, A. ( 1996 ) Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes. Acute Myelogenous Leukaemia and Myelodysplasia (ed. by B. Lowemberg), pp. 19 32. BailliÈre Tindall, London. | en_US |
dc.identifier.citedreference | Gadd, S., Majdic, O., Kasinrerk, W., Stockinger, H., Maurer, D., Eher, D., Knapp, W. ( 1990 ) M5, a phosphoinositol linked human myelo-monocytic activation associated antigen. Clinical and Experimental Immunology, 80, 252 256. | en_US |
dc.identifier.citedreference | Garni-Wagner, B.A. & Todd, R.F. ( 1995 ) Two epitopes within the ligand binding domain in the human urokinase receptor are defined by select mAb. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al ), Vol. 1, pp. 945 949. Oxford University Press. | en_US |
dc.identifier.citedreference | Gyetko, M.R., Chen, G.H., McDonald, R.A., Goodman, R., Huffnagle, G.B., Willkinson, C.C., Fuller, J.A., Toews, G.B. ( 1996 ) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. Journal of Clinical Investigation, 97, 1818 1826. | en_US |
dc.identifier.citedreference | Gyetko, M.R., Sitrin, R.G., Fuller, J., Todd, R.F., III, Petty, H., Standiford, T.J. ( 1995 ) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. Journal of Leukocyte Biology, 58, 533 538. | en_US |
dc.identifier.citedreference | Gyetko, M.R., Todd, R.F., Wilkinson, C.C., Sitrin, R.G. ( 1994 ) The urokinase receptor is required for human monocyte chemotaxis in vitro. Journal of Clinical Investigation, 93, 1380 1387. | en_US |
dc.identifier.citedreference | Kindzelskii, A.L., Laska, Z.O., Todd, R.F., Petty, H.R. ( 1996 ) Urokinase-type plasminogen activator receptor recversibly dissociates from complement receptor type III (alpha M beta 2′ CD11b/CD18) during neutrophil polarization. Journal of Immunology, 156, 297 309. | en_US |
dc.identifier.citedreference | Knapp, W., Strobl, H., Majdic, O. ( 1994 ) Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry, 18, 187 198. | en_US |
dc.identifier.citedreference | Lanza, F., Bi, S., Godman, J.M. ( 1993 ) Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia, 7, 1570 1575. | en_US |
dc.identifier.citedreference | Lanza, F., Campana, D., Knapp, W., Janossy, G., Lacombe, F., Matutes, E., Orfao, A., Schmitz, G. ( 1996 ) Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results?. European Journal of Histochemistry, 40, 7 14. | en_US |
dc.identifier.citedreference | Lanza, F., Castagnari, B., Rigolin, G.M., Moretti, S., Ferrari, L., Bardi, A., Castoldi, G.L. ( 1997 a) Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells. Leukemia, 11, 1700 1710. | en_US |
dc.identifier.citedreference | Lanza, F., Latorraca, A., Moretti, S., Castagnari, B., Ferrari, L., Castoldi, G.L. ( 1997 b) Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry, 30, 134 144. | en_US |
dc.identifier.citedreference | Lanza, F., Moretti, S., Papa, S., Malavasi, F., Castoldi, G.L. ( 1994 ) Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, 3–7 November, 1993. Haematologica, 79, 374 387. | en_US |
dc.identifier.citedreference | Lanza, F, Sucai, B., Moretti, S., Castoldi, G.L., Godman, J.M. ( 1995 ) Modulation of cell kinetics and cell cycle status by treating chronic myeloid leukaemia CD34 + cells with p53 antisense phophorothioate oligonucleotides. British Journal of Haematology, 90, 8 14. | en_US |
dc.identifier.citedreference | Lijnen, H.R. ( 1996 ) Pathophysiology of the plasminogen–plasmin system. International Journal of Clinical and Laboratory Research, 26, 1 6. | en_US |
dc.identifier.citedreference | Mizukami, I., Vinjamuri, S., Trochelman, D., Todd, R. ( 1990 ) Structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human polymorphonuclear phagocytes. Journal of Immunology, 144, 1841 1848. | en_US |
dc.identifier.citedreference | Papa, S. & Lanza, F. ( 1996 ) Immunophenotyping Hematological Malignancies. Luigi & Ponzio Editore, Pavia. | en_US |
dc.identifier.citedreference | Plesner, T., Ploug, M., Ellis, V., Ronne, E., Hoyer-Hansen, G., Wittrup, M., Pedersen, T.L., Tscherning, T., Dano, K., Hansen, N.E. ( 1994 ) The receptor for urokinase type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood, 83, 808 815. | en_US |
dc.identifier.citedreference | Poncelet, P., George, F., Papa, S., Lanza, F. ( 1996 ) Quantitation of hemopoietic cell antigens in flow cytometry. European Journal of Histochemistry, 40, 15 32. | en_US |
dc.identifier.citedreference | Pyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen, J., Eriksen, J., Blasi, F., Dano, K. ( 1991 ) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. American Journal of Pathology, 138, 1059 1065. | en_US |
dc.identifier.citedreference | Simon, D., Rao, N., Xu, H., Wei, Y., Majdic, O., Ronne, E., Kobzik, L., Chapman, H. ( 1996 ) Mac-1 (CD11b/ CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood, 88, 3185 3194. | en_US |
dc.identifier.citedreference | Sitrin, R.G., Todd, R.F., III, Mizukami, I.F., Gross, T.J., Shollenberger, S.B., Gyetko, M.R. ( 1994 ) Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood, 84, 1268 1275. | en_US |
dc.identifier.citedreference | Spisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Pagani Zecchini, G., Paglialunga Paradisi, M., Torrini, I., Ferretti, M.E. ( 1996 ) Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cellular Signaling, 8, 269 277. | en_US |
dc.identifier.citedreference | Spisani, S., Traniello, S., Martuccio, T., Rizzuti, O., Cellai, L. ( 1997 ) Ryfamycin inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity. Inflammation, 21, 391 400. | en_US |
dc.identifier.citedreference | Stephens, R., Tapiovaara, H., Alitalo, R., Reisberg, T., Lymboussakis, A., Myohanen, H., Vaheri, A. ( 1992 ) Cell surface plasminogen activation and leukemia. Fibrinolysis, 6, 35 39. | en_US |
dc.identifier.citedreference | Todd, R., III & Petty, H. ( 1997 ) β2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. Journal of Laboratory and Clinical Medicine, 129, 492 498. | en_US |
dc.identifier.citedreference | Todd, R.F., Barnathan, E.S., Bohuslav, J., Chapman, A., Cohen, R.L., Felez, J., Howell, J., Johnson, J.G., Knapp, W., Kramer, M., Miles, L.A., Nykjaer, A., Ralkiaer, E., Schuren, E. ( 1995 ) CD87 cluster workshop report. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al ), Vol. 1, pp. 932 939. Oxford University Press. | en_US |
dc.identifier.citedreference | Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V., Chapman, H.A. ( 1996 ) Regulation of integrin function by the urokinase receptor. Science, 273, 1551 1555. | en_US |
dc.identifier.citedreference | Xue, W., Kindzelskii, A.L., Todd, R.F., Petti, H.R. ( 1994 ) Physical association of complement receptor type 3 and urokinase type plasminogen activator receptor in neutrophil membranes. Journal of Immunology, 152, 4630 4638. | en_US |
dc.identifier.citedreference | Ye, R.D. & Boulay, F. ( 1997 ) Structure and function of leukocyte chemoattractant receptors. Advances in Pharmacology, 39, 221 289. | en_US |
dc.identifier.citedreference | Zigmond, S.H. & Hirsch, J.G. ( 1973 ) Leukocyte locomotion and chemotaxis, new method for evaluation and demonstration of a cell-derived chemotactic factor. Journal of Experimental Medicine, 137, 387 410. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.